Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.
Oncotarget. 2014 Aug 30;5(16):6633-46. doi: 10.18632/oncotarget.1955.
Oncotarget. 2014.
PMID: 24952873
Free PMC article.
Profile of neratinib and its potential in the treatment of breast cancer.
Feldinger K, Kong A.
Feldinger K, et al.
Breast Cancer (Dove Med Press). 2015 Jun 9;7:147-62. doi: 10.2147/BCTT.S54414. eCollection 2015.
Breast Cancer (Dove Med Press). 2015.
PMID: 26089701
Free PMC article.
Review.
Item in Clipboard
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.
Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, Whittington HJ, Lake HA, Zervou S, Lygate CA, Kessler BM, Harris AL.
Valli A, et al. Among authors: feldinger k.
Mol Cancer Res. 2019 Jul;17(7):1531-1544. doi: 10.1158/1541-7786.MCR-18-0315. Epub 2019 Mar 18.
Mol Cancer Res. 2019.
PMID: 30885992
Item in Clipboard
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models.
Arshad M, Azad A, Chan PYK, Vigneswara V, Feldinger K, Nafi SNM, Laporte-Maguire E, De Santo C, Zuo J, Shaaban AM, Kong A.
Arshad M, et al. Among authors: feldinger k.
Br J Cancer. 2024 Apr 10. doi: 10.1038/s41416-024-02665-z. Online ahead of print.
Br J Cancer. 2024.
PMID: 38600326
Item in Clipboard
Cite
Cite